Literature DB >> 12507413

Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.

David S Saperstein1, Richard J Barohn.   

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated demyelinating neuropathy. It is the most common treatable acquired polyneuropathy and represents a significant number of initially undiagnosed neuropathy patients. This article reviews the common clinical, laboratory, and electrodiagnostic features of CIDP. In addition, current areas of uncertainty are discussed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12507413     DOI： 10.1007/s11910-003-0039-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


  47 in total

1.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

2.  Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block.

Authors:  R K Olney
Journal:  Muscle Nerve Suppl       Date:  1999

3.  Conduction block in clinical practice.

Authors:  D R Cornblath; A J Sumner; J Daube; R W Gilliat; W F Brown; G J Parry; J W Albers; R G Miller; J Petajan
Journal:  Muscle Nerve       Date:  1991-09       Impact factor: 3.217

4.  Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis.

Authors:  N Mowzoon; A Sussman; W G Bradley
Journal:  J Neurol Sci       Date:  2001-04-01       Impact factor: 3.181

5.  Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J R Mendell; R J Barohn; M L Freimer; J T Kissel; W King; H N Nagaraja; R Rice; W W Campbell; P D Donofrio; C E Jackson; R A Lewis; M Shy; D M Simpson; G J Parry; M H Rivner; C A Thornton; M B Bromberg; R Tandan; Y Harati; M J Giuliani
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

6.  Chronic relapsing polyneuritis.

Authors:  J W Prineas; J G McLeod
Journal:  J Neurol Sci       Date:  1976-04       Impact factor: 3.181

7.  Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.

Authors:  A F Hahn; C F Bolton; N Pillay; C Chalk; T Benstead; V Bril; K Shumak; M K Vandervoort; T E Feasby
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

8.  Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.

Authors:  S J Hodgkinson; J D Pollard; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

9.  The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later.

Authors:  R J Barohn; Z Sahenk; J R Warmolts; J R Mendell
Journal:  Arch Neurol       Date:  1991-11

10.  Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy.

Authors:  M Sabatelli; T Mignogna; G Lippi; M Milone; V Di Lazzaro; P Tonali; E Bertini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154
View more
  1 in total

Review 1.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.